Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. | Biomolecules | 2023 | 37627318 | PubTator, text mining | PubMed |
| Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells. | Biomedicines | 2023 | 37626656 | PubTator, text mining | PubMed |
| A Review of the Current Literature on Pleomorphic Adenoma. | Cureus | 2023 | 37614271 | PubTator, text mining | PubMed |
| Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma. | Exp Ther Med | 2023 | 37602311 | PubTator, text mining | PubMed |
| NME3 binds to phosphatidic acid and mediates PLD6-induced mitochondrial tethering. | J Cell Biol | 2023 | 37584589 | PubTator, text mining | PubMed |
| Editorial: Editorial for mechanical and structural phenotypes of cells and extracellular matrices govern cell adhesion and migration. | Front Cell Dev Biol | 2023 | 37576605 | PubTator, text mining | PubMed |
| Distal Dorsal Thumb Mass: Giant Cell Tumor of the Tendon Sheath in an Unusual Location. | Cureus | 2023 | 37551250 | PubTator, text mining | PubMed |
| Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A). | Biomolecules | 2023 | 37509196 | PubTator, text mining | PubMed |
| Multicomponent Oxidative Nitrile Thiazolidination Reaction for Selective Modification of N-terminal Dimethylation Posttranslational Modification. | J Am Chem Soc | 2023 | 37486086 | PubTator, text mining | PubMed |
| The secretome as a biomarker and functional agent in heart failure. | J Cardiovasc Aging | 2023 | 37484982 | PubTator, text mining | PubMed |
| Lysosomes, curcumin, and anti-tumor effects: how are they linked? | Front Pharmacol | 2023 | 37484013 | PubTator, text mining | PubMed |
Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury. | BMC Neurosci | 2023 | 37474905 | PubTator, text mining | PubMed |
| Manipulating RKIP reverses the metastatic potential of breast cancer cells. | Front Oncol | 2023 | 37469399 | PubTator, text mining | PubMed |
| Icariin as a potential anticancer agent: a review of its biological effects on various cancers. | Front Pharmacol | 2023 | 37456751 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| Comparative Analysis of Water Extracts from Roselle (Hibiscus sabdariffa L.) Plants and Callus Cells: Constituents, Effects on Human Skin Cells, and Transcriptome Profiles. | Int J Mol Sci | 2023 | 37446030 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. | Int J Mol Sci | 2023 | 37445908 | PubTator, text mining | PubMed |
| Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37444584 | PubTator, text mining | PubMed |
| Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. | PLoS One | 2023 | 37418424 | PubTator, text mining | PubMed |
| Epstein‑Barr virus as a promoter of tumorigenesis in the tumor microenvironment of breast cancer (Review). | Int J Mol Med | 2023 | 37417334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=8